ArticleFrontiers in pharmacology2024

Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson's disease.

Qing-Wei Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.